Not for human or veterinary consumption
Little robust, reliable evidence supports current recommended dosing schedules, and no clinical studies assess the effectiveness and optimal dosing of intramuscular cobalamin preparations for symptom relief, other than studies assessing attained serum B 12 concentrations and sometimes haematological response
Sharabi A, Cohen E, Sulkes J, Garty M (2003) Replacement therapy for vitamin B12 deficiency: comparison between the sublingual and oral route
This method results in the inclusion of Medicaid prescriptions and gross spending for: Ozempic, Rybelsus, Mounjaro, Victoza, Trulicity, Wegovy, Zepbound, Saxenda, and generic liraglutide as well as a small number of prescriptions and spending for Adlyxin, Byetta, Bydureon BCise, and Tanzeum (now discontinued)